Literature DB >> 9177372

Blood pressure in children and adolescents with Cushing's syndrome before and after surgical care.

M A Magiakou1, G Mastorakos, K Zachman, G P Chrousos.   

Abstract

Approximately half of children and adolescents with Cushing's syndrome develop hypertension. To examine the role of hypercortisolism in the pathogenesis of hypertension in young patients and to establish its reversibility, we studied 31 hypertensive children and adolescents with Cushing's syndrome (systolic, diastolic, and/or mean blood pressure more than 2 SD U for age and sex) from a total of 63 patients before, and for a period of 1 yr after surgical cure. Preoperatively, 93.5%, 42%, and 45% of these patients presented with an increase of the systolic, diastolic, and mean blood pressure, respectively. The systolic blood pressure remained increased in 30.7%, 15.8%, and 5.5% of patients at 3, 6, and 12 months after surgical cure, respectively. The diastolic and mean blood pressure completely normalized by 3 months after surgical cure. A significant, positive correlation was observed between the systolic blood pressure and the duration of the disease, but no correlation was seen with the 24-h urinary free cortisol values and/or the patients' body mass indices. The lack of correlation between 24-h urinary free cortisol values and blood pressure suggests that hypercortisolism influences blood pressure through multiple pathways. The positive correlation between the systolic blood pressure and the duration of the disease points towards the deleterious effects of prolonged hypercortisolism and the significance of early diagnosis and treatment. The fact that the blood pressure normalized within a year from the correction of hypercortisolism suggests that, as a rule, young patients with hypercortisolism do not develop essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9177372     DOI: 10.1210/jcem.82.6.3985

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

Review 1.  Cushing's syndrome in children and adolescents: current diagnostic and therapeutic strategies.

Authors:  M A Magiakou; G P Chrousos
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

2.  Circadian blood pressure profile in patients with Cushing's syndrome before and after treatment.

Authors:  S Zacharieva; M Orbetzova; A Stoynev; R Shigarminova; M Yaneva; K Kalinov; E Nachev; A Elenkova
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

3.  Extensive and largely reversible ischemic cerebral infarctions in a prepubertal child with hypertension and Cushing disease.

Authors:  Jil Huong Nguyen; Maya B Lodish; Nicholas J Patronas; Figen Ugrasbul; Margaret F Keil; Mary D Roberts; Jadranka Popovic; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-01       Impact factor: 5.958

4.  Adrenal gland: Hypertension during remission of childhood Cushing syndrome.

Authors:  John Newell-Price
Journal:  Nat Rev Endocrinol       Date:  2009-11       Impact factor: 43.330

5.  Management of Cushing syndrome in children and adolescents: experience of a single tertiary centre.

Authors:  Maria Güemes; Philip G Murray; Caroline E Brain; Helen A Spoudeas; Catherine J Peters; Peter C Hindmarsh; Mehul T Dattani
Journal:  Eur J Pediatr       Date:  2016-05-12       Impact factor: 3.183

6.  Cushing's syndrome: all variants, detection, and treatment.

Authors:  Susmeeta T Sharma; Lynnette K Nieman
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

Review 7.  Glucocorticoid excess and hypertension.

Authors:  Smita Baid; Lynnette K Nieman
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

8.  Blood pressure in pediatric patients with Cushing syndrome.

Authors:  Maya B Lodish; Ninet Sinaii; Nicholas Patronas; Dalia L Batista; Meg Keil; Jonelle Samuel; Jason Moran; Somya Verma; Jadranka Popovic; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-03-17       Impact factor: 5.958

Review 9.  Quality of life and other outcomes in children treated for Cushing syndrome.

Authors:  Margaret F Keil
Journal:  J Clin Endocrinol Metab       Date:  2013-05-02       Impact factor: 5.958

10.  Reversible posterior encephalopathy syndrome associated with micronodular adrenocortical disease and Cushing syndrome.

Authors:  Maya Lodish; Nicholas J Patronas; Constantine A Stratakis
Journal:  Eur J Pediatr       Date:  2009-05-05       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.